Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.
Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser
Richard Liebano
This study aimed to assess the effectiveness of interferential current (IFC) therapy in alleviating symptoms and improving functional outcomes in patients experiencing persistent non-specific low back pain. A randomized controlled trial was conducted involving participants aged [18-65] with a diagnosis of on-going non-specific low back pain. Participants were randomly assigned to either the IFC intervention group or a control group receiving standard care. The IFC group received, while the control group continued with their routine care, which included [describe standard care, e.g., medications, physical therapy]. Outcome measures included pain intensity, functional disability, and health-related quality of life, assessed at baseline, post-treatment, and follow-up intervals. The study demonstrated a significant reduction in pain intensity and functional disability in the IFC group compared to the control group (p < 0.05). Moreover, participants in the IFC group reported improvements in health-related quality of life at follow-up assessments. The intervention was well-tolerated, with no reported adverse effects. Interferential current therapy emerged as an effective adjunctive treatment for individuals with on-going nonspecific low back pain, contributing to pain reduction, improved functionality, and enhanced quality of life. These findings support the integration of IFC into comprehensive pain management strategies for individuals grappling with persistent low back pain. Further research exploring long-term effects and optimal treatment parameters is warranted to refine clinical recommendations.